Phoenix A. Ho, MD, is attending physician at Seattle Children’s Hospital, acting instructor in the Division of Pediatric Hematology/Oncology at the University of Washington School of Medicine, and research associate in the Clinical Research Division at the Fred Hutchinson Cancer Research Center (FHCRC).
His clinical interests include the treatment of high-risk leukemia, including relapsed and refractory disease, while his research focus is the molecular biology of acute myeloid leukemia (AML). His interests include the molecular characterization of pediatric AML for the purposes of disease classification and risk stratification, and his work has included the study of mutations in leukemia-associated transcription factor genes such as CEBPA and WT1. Ho is also studying de-regulated signal transduction in AML, with a focus on the PI3K/Akt pathway. His goal is to translate his work into new treatments and better outcomes for children with AML.Â
Dr. Phoenix Anhdung Ho, MD
0
The iMedixStars rating goes beyond a simple average of reviews. It’s calculated based on various factors, including the quantity, recency, and reliability of the reviews. Read More
Overwiew
Doctor Organizations
- Seattle Childrens Hospital
Doctor Education
Medical School
2003
Northeast Ohio Medical University
Work Place
Seattle Children's Hospital
PO Box 5371
Seattle
WA
98145
USA
+12069872000
Specialties
Procedures performed
- Chemotherapy
Conditions
- Leukemia
- Sickle-Cell Disease
- Anemia
- Reviews
- Q&A
0 total
- 5 0 %
- 4 0 %
- 3 0 %
- 2 0 %
- 1 0 %
There are no questions!
Leave a comment